TABLE 4.
C. trachomatis prevalences in men and women as determined by the COBAS Amplicor and LCx tests and after discrepancy analysis
| Age | Males
|
Females
|
||||||
|---|---|---|---|---|---|---|---|---|
| na | No. (%) C. trachomatis positive
|
n | No. (%) C. trachomatis positive
|
|||||
| LCx | COBAS Amplicor | Trueb | LCx | COBAS Amplicor | True | |||
| 11–15 | 14 | 0 (0) | 0 (0) | 0 (0) | 20 | 1 (5.0) | 2 (10) | 2 (10) |
| 16–20 | 65 | 1 (1.5) | 3 (4.6) | 2 (3.1) | 108 | 4 (3.7) | 6 (5.6) | 7 (6.5) |
| 21–25 | 157 | 5 (3.2) | 7 (4.4) | 7 (4.4) | 284 | 8 (2.8) | 7 (2.5) | 6 (2.1) |
| 26–30 | 275 | 12 (4.4) | 12 (4.4) | 10 (3.6) | 466 | 11 (2.4) | 15 (3.2) | 15 (3.2) |
| 31–35 | 339 | 7 (2.1) | 9 (2.7) | 9 (2.7) | 453 | 14 (3.1) | 12 (2.6) | 12 (2.6) |
| 35–40 | 288 | 4 (4.1) | 4 (4.1) | 4 (4.1) | 386 | 8 (2.1) | 10 (2.6) | 10 (2.6) |
| 11–40 | 1,138 | 29 (2.5) | 35 (3.1) | 32 (2.8) | 1,717 | 46 (2.7) | 52 (3.0) | 52 (3.0) |
a
n, number of persons and urine specimens.
b
True, positive for C. trachomatis after discrepancy analysis.